Table 3 Characteristics of the surviving patients who were included in the final analysis
Baseline | Study end | |
|---|---|---|
Number of patients | 102 | |
Age (years) | 65.4 ± 12.1 | – |
Gender (m/f) | 54/48 | – |
Body mass index (kg/m2) | 22.4 ± 3.0 | 22.2 ± 3.3 |
Dialysis history (months) | 66.4 ± 57.6 | – |
Diabetes (%) | 42 (41) | – |
Hyperlipidemia drugs (%) | 10 (9.8) | – |
Systolic BP (mmHg) | 145 ± 22 | 145 ± 21 |
Diastolic BP (mmHg) | 79 ± 12 | 77 ± 13 |
Laboratory study | ||
Hemoglobin (g/dl) | 10.9 ± 0.9 | – |
High-density lipoprotein cholesterol (mg/dl) | 47.9 ± 16.0 | – |
Low-density lipoprotein cholesterol (mg/dl) | 86.1 ± 28.4 | – |
Triglyceride (mg/dl) | 96.9 ± 54.0 | – |
Uric acid (mg/dl) | 7.3 ± 1.2 | – |
Creatinine (mg/dl) | 10.2 ± 2.6 | – |
C-reactive protein (mg/dl) | 0.25 ± 0.70 | – |
Ca (mg/dl) | 8.9 ± 0.6 | – |
Inorganic phosphorus (mg/dl) | 5.1 ± 1.1 | – |
Intact parathyroid hormone (pg/ml) | 129.6 ± 82.8 | – |
Albumin (g/dl) | 3.7 ± 0.3 | – |
Hemoglobin A1c (%) | 5.23 ± 0.75 | – |
Human atrial natriuretic polypeptide (pg/ml) | 62.7 ± 63.5 | – |
Brain natriuretic peptide (pg/ml) | 214.3 ± 263.5 | – |
Cardiothoracic ratio (%) | 51.7 ± 4.8 | – |
Brachial-ankle pulse wave velocity (cm/s) | 1913 ± 446 | 2029 ± 546 |
Abdominal circumference (cm) | 83.4 ± 8.6 | 82.6 ± 9.4 |
Visceral fat area (cm2) | 86.2 ± 54.4 | 85.7 ± 54.0 |
Subcutaneous fat area (cm2) | 120.1 ± 62.7 | 117.9 ± 60.2 |